06996.HK
Antengene Corporation Limited
HKSE · Healthcare · Biotechnology · CN
HKD 2.83
−0.53%Margins
Gross margin
91.5%
EBITDA margin
31.0%
EBIT margin
27.9%
Net margin
9.1%
FCF margin
-23.3%
5.5%
Return on equity
3.3%
Return on assets
13.3%
Return on invested capital
0.40x
Asset turnover
-HKD 85.6M
Cash from operations
HKD 1.44
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026